Strong acquisition pipeline:
The recent acquisition of a big box hotel in Bengaluru is a significant milestone given that the international traffic at Bengaluru airport is expected to double in 3-5 years and there is no meaningful supply coming up in this micro-market. Hence, the operating hotels even in the upper upscale segment are currently commanding INR 10k+ ARR. The company is evaluating assets with similar dynamics in NCR, Hyderabad and Navi Mumbai and is targeting to close a few brownfield transactions within 3-4 months.
The recent acquisition of a big box hotel in Bengaluru is a significant milestone given that the international traffic at Bengaluru airport is expected to double in 3-5 years and there is no meaningful supply coming up in this micro-market. Hence, the operating hotels even in the upper upscale segment are currently commanding INR 10k+ ARR. The company is evaluating assets with similar dynamics in NCR, Hyderabad and Navi Mumbai and is targeting to close a few brownfield transactions within 3-4 months.
๐2โก1๐ฅ1๐ซก1
Value unlocking opportunity in Mumbai land:
Company owns two land parcels adjacent to GHM and it intends to develop a commercial tower on the 45k sft land. The development plans for the larger land parcel spanning 97k sft are not yet finalised. Given the insignificant acquisition cost and prime location (proximity to BKC and airport), these land parcels presents a significant value unlocking opportunity.
Company owns two land parcels adjacent to GHM and it intends to develop a commercial tower on the 45k sft land. The development plans for the larger land parcel spanning 97k sft are not yet finalised. Given the insignificant acquisition cost and prime location (proximity to BKC and airport), these land parcels presents a significant value unlocking opportunity.
โก2๐1๐ฅ1๐1
Company highlights:
- India has always been under-served in terms of hotel capacity. Given the healthy economic growth and formalisation of multiple sectors, the demand tailwinds are expected to stay for a couple of years - The management intends to remain focused on its core expertise of developing the assets and doesnโt prefer the asset light route for expansion - The GHM has potential to add 300 keys atop the existing structure and the company has already paid INR 420mn to get the approvals. However, the management prefers to sweat out the operating asset and the expansion will only be taken up after 2 years - While Hyatt will remain the key management partner, all the upcoming assets may not necessarily be tied up with Hyatt - The company will generate INR 30bn of OCF over the next 5 years and the total outlay towards capex during same period will be INR 18bn-19bn
- India has always been under-served in terms of hotel capacity. Given the healthy economic growth and formalisation of multiple sectors, the demand tailwinds are expected to stay for a couple of years - The management intends to remain focused on its core expertise of developing the assets and doesnโt prefer the asset light route for expansion - The GHM has potential to add 300 keys atop the existing structure and the company has already paid INR 420mn to get the approvals. However, the management prefers to sweat out the operating asset and the expansion will only be taken up after 2 years - While Hyatt will remain the key management partner, all the upcoming assets may not necessarily be tied up with Hyatt - The company will generate INR 30bn of OCF over the next 5 years and the total outlay towards capex during same period will be INR 18bn-19bn
โก2โค1๐1๐ฅ1๐1๐ซก1
Juniper Hotel 260-312
Expected level 400
Support 220
Expected level 400
Support 220
๐ฅ5๐1๐1
Galaxy surfactants company details
A decade of strong foundations and profitable growth ๏ฎ Over the past 10 years, GALSURF has demonstrated its ability to scale profitably while navigating cyclical and regional challenges. During FY15-25, the company doubled its total volumes, supported by deeper market penetration and category expansion, particularly in rinse-off personal care and home care products. During this same period, EBITDA tripled, driven by operational efficiencies, product mix enhancement, and innovation. PAT grew 5x, reflecting sharp execution and cost control. ๏ฎ GALSURF achieved an average RoCE of 22%, a testament to disciplined capital allocation and return-oriented investment. EBITDA/kg also doubled, highlighting the companyโs ability to extract more value per unit of product. Despite macroeconomic headwinds in the early part of this decade, including inflation and demand volatility, the company maintained strong profitability, setting a firm base for future expansion.
A decade of strong foundations and profitable growth ๏ฎ Over the past 10 years, GALSURF has demonstrated its ability to scale profitably while navigating cyclical and regional challenges. During FY15-25, the company doubled its total volumes, supported by deeper market penetration and category expansion, particularly in rinse-off personal care and home care products. During this same period, EBITDA tripled, driven by operational efficiencies, product mix enhancement, and innovation. PAT grew 5x, reflecting sharp execution and cost control. ๏ฎ GALSURF achieved an average RoCE of 22%, a testament to disciplined capital allocation and return-oriented investment. EBITDA/kg also doubled, highlighting the companyโs ability to extract more value per unit of product. Despite macroeconomic headwinds in the early part of this decade, including inflation and demand volatility, the company maintained strong profitability, setting a firm base for future expansion.
โค3โก1๐1๐ฅ1๐ซก1
Vision 2030
๏ฎ Looking ahead to 2030, GALSURF has outlined an ambitious but well-structured growth roadmap. Over the next five years, the company plans to double its volumes and grow EBITDA by 2.5x, while sustaining a RoCE greater than 22%. Its key internal goal is to achieve an EBITDA/kg of INR25 by FY30. This growth will be driven by a mix of organic, portfolio-led, and ecosystem-driven initiatives. ๏ฎ The company expects 50% of incremental EBITDA to come from organic growth in rinse-off categories such as hair care, oral care, and body washโ segments where GALSURF already has a strong presence. Around 30% of EBITDA growth is projected to come from new product portfolios, particularly in high-value, leave-on categories like moisturizers, sunscreens, and serums. The remaining 20% will be driven by new avenues, including strategic partnerships, collaborations, and expansion into wellness and beauty-focused solutions. ๏ฎ GALSURF's 2030 vision is centered on defending and deepening its leadership in India and AMET markets, winning new customers and applications in the Americas, and making focused inroads into specialties in the European Union. This will be enabled through what the management calls the โ3Dโ approachโ Development, Digitalization, and Distributionโbacked by investments in innovation, technology, and talent.
๏ฎ Looking ahead to 2030, GALSURF has outlined an ambitious but well-structured growth roadmap. Over the next five years, the company plans to double its volumes and grow EBITDA by 2.5x, while sustaining a RoCE greater than 22%. Its key internal goal is to achieve an EBITDA/kg of INR25 by FY30. This growth will be driven by a mix of organic, portfolio-led, and ecosystem-driven initiatives. ๏ฎ The company expects 50% of incremental EBITDA to come from organic growth in rinse-off categories such as hair care, oral care, and body washโ segments where GALSURF already has a strong presence. Around 30% of EBITDA growth is projected to come from new product portfolios, particularly in high-value, leave-on categories like moisturizers, sunscreens, and serums. The remaining 20% will be driven by new avenues, including strategic partnerships, collaborations, and expansion into wellness and beauty-focused solutions. ๏ฎ GALSURF's 2030 vision is centered on defending and deepening its leadership in India and AMET markets, winning new customers and applications in the Americas, and making focused inroads into specialties in the European Union. This will be enabled through what the management calls the โ3Dโ approachโ Development, Digitalization, and Distributionโbacked by investments in innovation, technology, and talent.
โค1๐1๐ฅ1๐1
Riding on global trends:
A shifting industry landscape ๏ฎ GALSURF operates in an ingredients market with a total addressable value of USD42b, of which USD30b is directly relevant to its surfactants and specialty chemicals portfolio. The total global ingredient volume stands at 15mmt, with GALSURFโs focus market comprising 10mmt, of which 9mmt is surfactants and 1mmt includes preservatives, UV protection, and emollients. ๏ฎ The global home care ingredients market is estimated at USD26b, dominated by surfactants (72% share). Evolving consumer preferences in developed markets are driving demand for unit dose detergents (pods), eco-friendly formats, and low-residue formulations due to stricter regulatory norms (e.g., 1,4-Dioxane limits). Meanwhile, in developing regions, there is a shift from bar and powder-based formats to liquids and premium detergents, opening new avenues for GALSURF. ๏ฎ In the personal and beauty care segment, which is a USD475b market globally, GALSURF sees immense opportunities, especially in skincare, sun care, and clean beauty. The ingredients market within this segment is USD16b in value and 4mmt in volume. With a 5.7% CAGR, it is expected to outpace other segments, led by consumer shifts towards natural, multifunctional, and sustainable solutions.
A shifting industry landscape ๏ฎ GALSURF operates in an ingredients market with a total addressable value of USD42b, of which USD30b is directly relevant to its surfactants and specialty chemicals portfolio. The total global ingredient volume stands at 15mmt, with GALSURFโs focus market comprising 10mmt, of which 9mmt is surfactants and 1mmt includes preservatives, UV protection, and emollients. ๏ฎ The global home care ingredients market is estimated at USD26b, dominated by surfactants (72% share). Evolving consumer preferences in developed markets are driving demand for unit dose detergents (pods), eco-friendly formats, and low-residue formulations due to stricter regulatory norms (e.g., 1,4-Dioxane limits). Meanwhile, in developing regions, there is a shift from bar and powder-based formats to liquids and premium detergents, opening new avenues for GALSURF. ๏ฎ In the personal and beauty care segment, which is a USD475b market globally, GALSURF sees immense opportunities, especially in skincare, sun care, and clean beauty. The ingredients market within this segment is USD16b in value and 4mmt in volume. With a 5.7% CAGR, it is expected to outpace other segments, led by consumer shifts towards natural, multifunctional, and sustainable solutions.
โค1๐ฅ1๐ซก1
AMET and RoW:
From stabilization to acceleration ๏ฎ Between FY21 and FY25, GALSURF faced significant challenges in the Africa, Middle East, and Turkey (AMET) region due to inflation, geopolitical disruptions, and strong local competitors. Despite these hurdles, the company gained market share by leveraging its strong MNC relationships, local manufacturing capabilities, and innovative product offerings. Going forward, improving macroeconomic conditions and a shift in consumer behavior towards premium and clean products are expected to result in a 10-12% volume CAGR in the AMET region during the second half of the decade. ๏ฎ In the Rest of the World (RoW) markets, including Europe and parts of Asia Pacific, GALSURF experienced demand softness due to destocking cycles and delayed product launches. In response, the company established a subsidiary in Europe to build a regional ecosystem, enabling faster and more efficient service to local demand. Going forward, growth in these markets is expected to be driven by private labels, D2C brands, and expansion into specialty categories, supported by an emphasis on sustainability, bio-based ingredients, and regulatory compliance.
From stabilization to acceleration ๏ฎ Between FY21 and FY25, GALSURF faced significant challenges in the Africa, Middle East, and Turkey (AMET) region due to inflation, geopolitical disruptions, and strong local competitors. Despite these hurdles, the company gained market share by leveraging its strong MNC relationships, local manufacturing capabilities, and innovative product offerings. Going forward, improving macroeconomic conditions and a shift in consumer behavior towards premium and clean products are expected to result in a 10-12% volume CAGR in the AMET region during the second half of the decade. ๏ฎ In the Rest of the World (RoW) markets, including Europe and parts of Asia Pacific, GALSURF experienced demand softness due to destocking cycles and delayed product launches. In response, the company established a subsidiary in Europe to build a regional ecosystem, enabling faster and more efficient service to local demand. Going forward, growth in these markets is expected to be driven by private labels, D2C brands, and expansion into specialty categories, supported by an emphasis on sustainability, bio-based ingredients, and regulatory compliance.
โค2๐ฅ1๐1๐1
Innovation as a core growth driver
๏ฎ Innovation is deeply embedded in GALSURFโs DNA. The company has launched 25 new products over the past decade and plans to launch more than 20 over the next five years. R&D spending has steadily increased from 0.5% of revenue in FY15 to 0.9% in FY25 and is expected to reach 2% by FY30, enabling highquality, scalable, and sustainable product development
Future innovation will center on bio-based surfactants, non-toxic preservatives, modern sun care actives, anti-aging and hair growth actives, and customized specialty blends. These innovations will allow GALSURF to meet the rising demand for clean, green, and high-performance ingredients, especially from D2C brands and conscious consumers worldwide
๏ฎ Innovation is deeply embedded in GALSURFโs DNA. The company has launched 25 new products over the past decade and plans to launch more than 20 over the next five years. R&D spending has steadily increased from 0.5% of revenue in FY15 to 0.9% in FY25 and is expected to reach 2% by FY30, enabling highquality, scalable, and sustainable product development
Future innovation will center on bio-based surfactants, non-toxic preservatives, modern sun care actives, anti-aging and hair growth actives, and customized specialty blends. These innovations will allow GALSURF to meet the rising demand for clean, green, and high-performance ingredients, especially from D2C brands and conscious consumers worldwide
โก1๐ฅ1๐1
Inorganic expansion:
Targeted, tech-led, and global ๏ฎ To complement organic growth, GALSURF has laid out a clear inorganic growth blueprint. The company intends to pursue niche acquisitions in the space of natural, sustainable, and biotech-based ingredients, which are rapidly gaining traction in clean beauty and wellness segments. It is also exploring technologydriven firms with proprietary innovations such as green delivery systems and encapsulation. ๏ฎ GALSURF is looking to expand its geographic presence by acquiring local players in key markets to accelerate access and consolidate leadership. Additionally, it plans to pursue strategic collaborations with global brand owners and private label manufacturers to gain deeper integration into end-consumer product ecosystems.
Targeted, tech-led, and global ๏ฎ To complement organic growth, GALSURF has laid out a clear inorganic growth blueprint. The company intends to pursue niche acquisitions in the space of natural, sustainable, and biotech-based ingredients, which are rapidly gaining traction in clean beauty and wellness segments. It is also exploring technologydriven firms with proprietary innovations such as green delivery systems and encapsulation. ๏ฎ GALSURF is looking to expand its geographic presence by acquiring local players in key markets to accelerate access and consolidate leadership. Additionally, it plans to pursue strategic collaborations with global brand owners and private label manufacturers to gain deeper integration into end-consumer product ecosystems.
โค2๐1๐คฉ1๐1
Disciplined capital allocation, risks, and mitigation strategies
๏ฎ GALSURFโs capital allocation philosophy is rooted in prudence and a strong focus on long-term shareholder value. From FY25 to FY30, the company plans to allocate 50-60% of its operational cash flows to organic growth opportunities, including capacity expansions and digital upgrades. It has earmarked 15% for dividend payouts, balancing growth and returns. The remaining capital will be reserved for strategic acquisitions and partnerships, in line with the Vision 2030 roadmap. ๏ฎ Historically, GALSURFโs capex has delivered strong returnsโwith RoCE of 1624% in prior investment cycles, validating its ability to scale profitably. Key investments in Taloja, Gujarat, Egypt, and the US have created a globally competitive manufacturing and innovation backbone. ๏ฎ GALSURF operates in a dynamic industry with several evolving risks. Inflation and raw material cost volatility could lead to downtrading by consumers and exert margin pressures. The slower funding environment for D2C brands, particularly in developed markets, may affect the scale-up of niche product lines. Additionally, regulatory tightening and delays in new product approvals pose challenges. ๏ฎ To mitigate these risks, the company relies on its diverse market base, broad product portfolio, and proactive approach to regulatory compliance and customer engagement. Its focus on sustainability, digital enablement, and robust supply chains ensures it remains agile and resilient.
๏ฎ GALSURFโs capital allocation philosophy is rooted in prudence and a strong focus on long-term shareholder value. From FY25 to FY30, the company plans to allocate 50-60% of its operational cash flows to organic growth opportunities, including capacity expansions and digital upgrades. It has earmarked 15% for dividend payouts, balancing growth and returns. The remaining capital will be reserved for strategic acquisitions and partnerships, in line with the Vision 2030 roadmap. ๏ฎ Historically, GALSURFโs capex has delivered strong returnsโwith RoCE of 1624% in prior investment cycles, validating its ability to scale profitably. Key investments in Taloja, Gujarat, Egypt, and the US have created a globally competitive manufacturing and innovation backbone. ๏ฎ GALSURF operates in a dynamic industry with several evolving risks. Inflation and raw material cost volatility could lead to downtrading by consumers and exert margin pressures. The slower funding environment for D2C brands, particularly in developed markets, may affect the scale-up of niche product lines. Additionally, regulatory tightening and delays in new product approvals pose challenges. ๏ฎ To mitigate these risks, the company relies on its diverse market base, broad product portfolio, and proactive approach to regulatory compliance and customer engagement. Its focus on sustainability, digital enablement, and robust supply chains ensures it remains agile and resilient.
โค2๐1๐ฅ1๐ซก1
Valuation and view
๏ฎ We believe that going forward, volume growth will be driven by the companyโs steady focus on R&D (with an annual expenditure of INR400-500m), increased wallet share from its existing customers, and acquisition of new customers. Margin is also likely to expand gradually with an increase in the volume of premium specialty products. ๏ฎ We estimate a volume CAGR of 6% over FY25-27, driven by improving volumes in the Specialty Care segment across developed markets and a recovery in demand, albeit gradual, from rural and urban markets in India. The stock is currently trading at ~22x FY27E EPS of INR106 and ~14x FY27E EV/EBITDA. We value the company at 30x FY27E EPS to arrive at a TP of INR3,180. We reiterate our BUY rating on the stock.
๏ฎ We believe that going forward, volume growth will be driven by the companyโs steady focus on R&D (with an annual expenditure of INR400-500m), increased wallet share from its existing customers, and acquisition of new customers. Margin is also likely to expand gradually with an increase in the volume of premium specialty products. ๏ฎ We estimate a volume CAGR of 6% over FY25-27, driven by improving volumes in the Specialty Care segment across developed markets and a recovery in demand, albeit gradual, from rural and urban markets in India. The stock is currently trading at ~22x FY27E EPS of INR106 and ~14x FY27E EV/EBITDA. We value the company at 30x FY27E EPS to arrive at a TP of INR3,180. We reiterate our BUY rating on the stock.
๐ฅ2โก1โค1๐1